Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
defibrotide adenosine receptor a1 biotech NA drugbank Lung[MeSHID:D008168]
Hepatic Veno-Occlusive Disease[MeSHID:D006504]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
defibrotide adenosine receptor a1 biotech NA drugbank Lung[MeSHID:D008168]
Hepatic Veno-Occlusive Disease[MeSHID:D006504]
Kidney[MeSHID:D007668]
Diabetic Nephropathy[MeSHID:D003928]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational unknown
defibrotide adenosine receptor a2a biotech NA drugbank Lung[MeSHID:D008168]
Hepatic Veno-Occlusive Disease[MeSHID:D006504]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
defibrotide adenosine receptor a2a biotech NA drugbank Lung[MeSHID:D008168]
Hepatic Veno-Occlusive Disease[MeSHID:D006504]
Kidney[MeSHID:D007668]
Diabetic Nephropathy[MeSHID:D003928]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational unknown
defibrotide adenosine receptor a2b biotech NA drugbank Lung[MeSHID:D008168]
Hepatic Veno-Occlusive Disease[MeSHID:D006504]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
defibrotide adenosine receptor a2b biotech NA drugbank Lung[MeSHID:D008168]
Hepatic Veno-Occlusive Disease[MeSHID:D006504]
Kidney[MeSHID:D007668]
Diabetic Nephropathy[MeSHID:D003928]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational unknown
click here to return to the previous page